81 FR 68021 - Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine Drug Testing for Federal Agencies
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration Federal Register Volume 81, Issue 191 (October 3, 2016)
Substance Abuse and Mental Health Services Administration
Federal Register Volume 81, Issue 191 (October 3, 2016)
| Page Range | 68021-68023 | |
| FR Document | 2016-23796 |
[Federal Register Volume 81, Number 191 (Monday, October 3, 2016)] [Notices] [Pages 68021-68023] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2016-23796] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine Drug Testing for Federal Agencies AGENCY: Substance Abuse and Mental Health Services Administration, HHS ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: The Department of Health and Human Services (HHS) notifies federal agencies of the laboratories and Instrumented Initial Testing Facilities (IITF) currently certified to meet the standards of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines). The Mandatory Guidelines were first published in the Federal Register on April 11, 1988 (53 FR 11970), and subsequently revised in the Federal Register on June 9, 1994 (59 FR 29908); September 30, 1997 (62 FR 51118); April 13, 2004 (69 FR 19644); November 25, 2008 (73 FR 71858); December 10, 2008 (73 FR 75122); and on April 30, 2010 (75 FR 22809). A notice listing all currently HHS-certified laboratories and IITFs is published in the Federal Register during the first week of each month. If any laboratory or IITF certification is suspended or revoked, the laboratory or IITF will be omitted from subsequent lists until such time as it is restored to full certification under the Mandatory Guidelines. If any laboratory or IITF has withdrawn from the HHS National Laboratory Certification Program (NLCP) during the past month, it will be listed at the end and will be omitted from the monthly listing thereafter. This notice is also available on the Internet at http://www.samhsa.gov/workplace. FOR FURTHER INFORMATION CONTACT: Giselle Hersh, Division of Workplace Programs, SAMHSA/CSAP, 5600 Fishers Lane, Room 16N03A, Rockville, Maryland 20857; 240-276-2600 (voice). SUPPLEMENTARY INFORMATION: The Mandatory Guidelines were initially developed in accordance with Executive Order 12564 and section 503 of Public Law 100-71. The ``Mandatory Guidelines for Federal Workplace Drug Testing Programs,'' as amended in the revisions listed above, requires strict standards that laboratories and IITFs must meet in order to conduct drug and [[Page 68022]] specimen validity tests on urine specimens for federal agencies. To become certified, an applicant laboratory or IITF must undergo three rounds of performance testing plus an on-site inspection. To maintain that certification, a laboratory or IITF must participate in a quarterly performance testing program plus undergo periodic, on-site inspections. Laboratories and IITFs in the applicant stage of certification are not to be considered as meeting the minimum requirements described in the HHS Mandatory Guidelines. A HHS-certified laboratory or IITF must have its letter of certification from HHS/SAMHSA (formerly: HHS/NIDA), which attests that it has met minimum standards. In accordance with the Mandatory Guidelines dated November 25, 2008 (73 FR 71858), the following HHS-certified laboratories and IITFs meet the minimum standards to conduct drug and specimen validity tests on urine specimens: HHS-Certified Instrumented Initial Testing Facilities Dynacare, 6628 50th Street NW., Edmonton, AB Canada T6B 2N7, 780-784- 1190, (Formerly: Gamma-Dynacare Medical Laboratories). HHS-Certified Laboratories ACM Medical Laboratory, Inc., 160 Elmgrove Park, Rochester, NY 14624, 585-429-2264. Aegis Analytical Laboratories, Inc., 345 Hill Ave., Nashville, TN 37210, 615-255-2400, (Formerly: Aegis Sciences Corporation, Aegis Analytical Laboratories, Inc., Aegis Analytical Laboratories). Alere Toxicology Services, 1111 Newton St., Gretna, LA 70053, 504-361- 8989/800-433-3823, (Formerly: Kroll Laboratory Specialists, Inc., Laboratory Specialists, Inc.). Alere Toxicology Services, 450 Southlake Blvd., Richmond, VA 23236, 804-378-9130, (Formerly: Kroll Laboratory Specialists, Inc., Scientific Testing Laboratories, Inc.; Kroll Scientific Testing Laboratories, Inc.). Baptist Medical Center-Toxicology Laboratory, 11401 I-30, Little Rock, AR 72209-7056, 501-202-2783, (Formerly: Forensic Toxicology Laboratory Baptist Medical Center). Clinical Reference Laboratory, Inc., 8433 Quivira Road, Lenexa, KS 66215-2802, 800-445-6917. DrugScan, Inc., 200 Precision Road, Suite 200, Horsham, PA 19044, 800- 235-4890. Dynacare *, 245 Pall Mall Street, London, ONT, Canada N6A 1P4, 519-679- 1630, (Formerly: Gamma-Dynacare Medical Laboratories). ElSohly Laboratories, Inc., 5 Industrial Park Drive, Oxford, MS 38655, 662-236-2609. Fortes Laboratories, Inc., 25749 SW Canyon Creek Road, Suite 600, Wilsonville, OR 97070, 503-486-1023. Laboratory Corporation of America Holdings, 7207 N. Gessner Road, Houston, TX 77040, 713-856-8288/800-800-2387. Laboratory Corporation of America Holdings, 69 First Ave., Raritan, NJ 08869, 908-526-2400/800-437-4986, (Formerly: Roche Biomedical Laboratories, Inc.). Laboratory Corporation of America Holdings, 1904 Alexander Drive, Research Triangle Park, NC 27709, 919-572-6900/800-833-3984, (Formerly: LabCorp Occupational Testing Services, Inc., CompuChem Laboratories, Inc.; CompuChem Laboratories, Inc., A Subsidiary of Roche Biomedical Laboratory; Roche CompuChem Laboratories, Inc., A Member of the Roche Group). Laboratory Corporation of America Holdings, 1120 Main Street, Southaven, MS 38671 866-827-8042/800-233-6339, (Formerly: LabCorp Occupational Testing Services, Inc.; MedExpress/National Laboratory Center). LabOne, Inc. d/b/a Quest Diagnostics, 10101 Renner Blvd., Lenexa, KS 66219, 913-888-3927/800-873-8845, (Formerly: Quest Diagnostics Incorporated; LabOne, Inc.; Center for Laboratory Services, a Division of LabOne, Inc.). MedTox Laboratories, Inc., 402 W. County Road D, St. Paul, MN 55112, 651-636-7466/800-832-3244. MetroLab-Legacy Laboratory Services, 1225 NE 2nd Ave., Portland, OR 97232, 503-413-5295/800-950-5295. Minneapolis Veterans Affairs Medical Center, Forensic Toxicology Laboratory, 1 Veterans Drive, Minneapolis, MN 55417, 612-725-2088, Testing for Veterans Affairs (VA) Employees Only. National Toxicology Laboratories, Inc., 1100 California Ave., Bakersfield, CA 93304, 661-322-4250/800-350-3515. One Source Toxicology Laboratory, Inc., 1213 Genoa-Red Bluff, Pasadena, TX 77504, 888-747-3774, (Formerly: University of Texas Medical Branch, Clinical Chemistry Division; UTMB Pathology-Toxicology Laboratory). Pacific Toxicology Laboratories, 9348 DeSoto Ave., Chatsworth, CA 91311, 800-328-6942, (Formerly: Centinela Hospital Airport Toxicology Laboratory). Pathology Associates Medical Laboratories, 110 West Cliff Dr., Spokane, WA 99204, 509-755-8991/800-541-7891x7. Phamatech, Inc., 15175 Innovation Drive, San Diego, CA 92128, 888-635- 5840. Quest Diagnostics Incorporated, 1777 Montreal Circle, Tucker, GA 30084, 800-729-6432, (Formerly: SmithKline Beecham Clinical Laboratories; SmithKline Bio-Science Laboratories). Quest Diagnostics Incorporated, 400 Egypt Road, Norristown, PA 19403, 610-631-4600/877-642-2216, (Formerly: SmithKline Beecham Clinical Laboratories; SmithKline Bio-Science Laboratories). Quest Diagnostics Incorporated, 8401 Fallbrook Ave., West Hills, CA 91304, 818-737-6370, (Formerly: SmithKline Beecham Clinical Laboratories). Redwood Toxicology Laboratory, 3700650 Westwind Blvd., Santa Rosa, CA 95403, 800-255-2159. Southwest Laboratories, 4625 E. Cotton Center Boulevard, Suite 177, Phoenix, AZ 85040, 602-438-8507/800-279-0027. STERLING Reference Laboratories, 2617 East L Street, Tacoma, Washington 98421, 800-442-0438. US Army Forensic Toxicology Drug Testing Laboratory, 2490 Wilson St., Fort George G. Meade, MD 20755-5235, 301-677-7085, Testing for Department of Defense (DoD) Employees Only. * The Standards Council of Canada (SCC) voted to end its Laboratory Accreditation Program for Substance Abuse (LAPSA) effective May 12, 1998. Laboratories certified through that program were accredited to conduct forensic urine drug testing as required by U.S. Department of Transportation (DOT) regulations. As of that date, the certification of those accredited Canadian laboratories will continue under DOT authority. The responsibility for conducting quarterly performance testing plus periodic on-site inspections of those LAPSA-accredited laboratories was transferred to the U.S. HHS, with the HHS' NLCP contractor continuing to have an active role in the performance testing and laboratory inspection processes. Other Canadian laboratories wishing to be considered for the NLCP may apply directly to the NLCP contractor just as U.S. laboratories do. Upon finding a Canadian laboratory to be qualified, HHS will recommend that DOT certify the laboratory (Federal Register, July 16, 1996) as meeting the minimum standards of the Mandatory Guidelines published in the Federal Register on April 30, 2010 (75 FR [[Page 68023]] 22809). After receiving DOT certification, the laboratory will be included in the monthly list of HHS-certified laboratories and participate in the NLCP certification maintenance program. Charles LoDico, Chemist. [FR Doc. 2016-23796 Filed 9-30-16; 8:45 am] BILLING CODE 4160-20-P
![Federal Register / Vol. 81, No. 191 / Monday, October 3, 2016 / Notices 68021
required but a specific due date was not 496–2229 or by email DEPARTMENT OF HEALTH AND
stated. Robert.eisinger@nih.gov. HUMAN SERVICES
(2) Any Appendix submitted for Step
Dated: September 27, 2016.
1 of the Challenge competition must be Substance Abuse and Mental Health
limited to 5 pages or less in length. If Lawrence A. Tabak, Services Administration
a longer Appendix is submitted, only Deputy Director, National Institutes of Health.
the first 5 pages will be considered by [FR Doc. 2016–23854 Filed 9–30–16; 8:45 am] Current List of HHS-Certified
the Technical Evaluation Panel and the BILLING CODE 4140–01–P
Laboratories and Instrumented Initial
Judging Panel. The September 8, 2016, Testing Facilities Which Meet Minimum
announcement incorrectly stated that Standards To Engage in Urine Drug
there was no page length for the DEPARTMENT OF HEALTH AND Testing for Federal Agencies
Appendix material. HUMAN SERVICES AGENCY: Substance Abuse and Mental
(3) Submissions for Step 1 of the
Health Services Administration, HHS
Challenge competition received after the National Institutes of Health
deadline of January 9, 2017, at 11:59 ACTION: Notice.
p.m. ET will be disqualified and not National Institute of Allergy and
Infectious Diseases; Notice of Closed SUMMARY: The Department of Health and
evaluated by the Technical Evaluation
Human Services (HHS) notifies federal
Panel or Judging Panel. Meeting
(4) Solvers may submit corrections or agencies of the laboratories and
additional materials in support of their Pursuant to section 10(d) of the Instrumented Initial Testing Facilities
Step 1 submissions so long as the NIH Federal Advisory Committee Act, as (IITF) currently certified to meet the
receives the materials by the deadline of standards of the Mandatory Guidelines
amended (5 U.S.C. App.), notice is
January 9, 2017, at 11:59 p.m. ET. for Federal Workplace Drug Testing
hereby given of the following meeting.
Corrections or additional materials for Programs (Mandatory Guidelines). The
The meeting will be closed to the Mandatory Guidelines were first
Step 1 will not be accepted or evaluated
public in accordance with the published in the Federal Register on
by the Technical Evaluation Panel or
provisions set forth in sections April 11, 1988 (53 FR 11970), and
Judging Panel if they are received after
January 9, 2017 at 11:59 p.m. ET. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., subsequently revised in the Federal
(5) The NIH will perform an initial as amended. The grant applications and Register on June 9, 1994 (59 FR 29908);
review of all submissions to ensure they the discussions could disclose September 30, 1997 (62 FR 51118);
are complete and within the scope of confidential trade secrets or commercial April 13, 2004 (69 FR 19644); November
the Challenge competition. Submissions property such as patentable material, 25, 2008 (73 FR 71858); December 10,
that are incomplete will be and personal information concerning 2008 (73 FR 75122); and on April 30,
administratively disqualified and will individuals associated with the grant 2010 (75 FR 22809).
not be evaluated by the Technical applications, the disclosure of which A notice listing all currently HHS-
Evaluation Panel or the Judging Panel. would constitute a clearly unwarranted certified laboratories and IITFs is
(6) The NIH and Assistant Secretary invasion of personal privacy. published in the Federal Register
for Preparedness and Response/ during the first week of each month. If
Name of Committee: National Institute of any laboratory or IITF certification is
Biomedical Advanced Research and
Allergy and Infectious Diseases Special suspended or revoked, the laboratory or
Development Authority may determine Emphasis Panel; NIAID Clinical Trial
that based on the number of IITF will be omitted from subsequent
Planning Grant (R34) and NIAID Investigator
submissions received for Step 1 that less lists until such time as it is restored to
Initiated Program Project Applications (P01).
competitive submissions will not be full certification under the Mandatory
Date: October 28, 2016.
discussed by the Technical Evaluation Guidelines.
Time: 8:00 a.m. to 3:00 p.m.
Panel during the Panel’s meeting. If any laboratory or IITF has
Agenda: To review and evaluate grant
(7) The ‘‘Solver’’ needs to address the applications.
withdrawn from the HHS National
NIH Human Subjects Protections and Place: National Institutes of Health, 5601
Laboratory Certification Program (NLCP)
Inclusion of Women, Children, and Fishers Lane, Rockville, MD 20892, during the past month, it will be listed
Minorities policies in their submissions (Telephone Conference Call). at the end and will be omitted from the
for Step 1 of this competition. Contact Person: Zhuqing (Charlie) Li, monthly listing thereafter.
(8) Members of the Technical Ph.D., Scientific Review Officer, Scientific This notice is also available on the
Evaluation Panel are not eligible to Review Program, Division of Extramural Internet at http://www.samhsa.gov/
participate in or contribute to any Activities, Room # 3G41B, National Institutes workplace.
proposal for Step 2 and Step 3 of the of Health/NIAID, 5601 Fishers Lane, FOR FURTHER INFORMATION CONTACT:
Challenge competition. MSC9823 Bethesda, MD 20892–9823, (240)
(9) Any Solver is eligible for Step 2 of Giselle Hersh, Division of Workplace
669–5068, zhuqing.li@nih.gov. Programs, SAMHSA/CSAP, 5600
this Challenge competition. For
example, if a Step 1 ‘‘Solver’’ is not
(Catalogue of Federal Domestic Assistance Fishers Lane, Room 16N03A, Rockville,
Program Nos. 93.855, Allergy, Immunology, Maryland 20857; 240–276–2600 (voice).
identified as a semifinalist, he/she may
and Transplantation Research; 93.856, SUPPLEMENTARY INFORMATION: The
still submit for Step 2 of this
Microbiology and Infectious Diseases Mandatory Guidelines were initially
competition and those who did not
Research, National Institutes of Health, HHS) developed in accordance with Executive
sradovich on DSK3GMQ082PROD with NOTICES
submit a Step 1 proposal may still
submit a proposal for Step 2. Dated: September 27, 2016. Order 12564 and section 503 of Public
(10) All submissions for Step 1, 2, and Natasha M. Copeland, Law 100–71. The ‘‘Mandatory
3 must be in English. Program Analyst, Office of Federal Advisory Guidelines for Federal Workplace Drug
For further information about the Committee Policy. Testing Programs,’’ as amended in the
Antimicrobial Resistance Diagnostic [FR Doc. 2016–23736 Filed 9–30–16; 8:45 am]
revisions listed above, requires strict
Challenge competition, please contact standards that laboratories and IITFs
BILLING CODE 4140–01–P
Robert W. Eisinger, Ph.D., NIH, 301– must meet in order to conduct drug and
VerDate Sep<11>2014 17:56 Sep 30, 2016 Jkt 241001 PO 00000 Frm 00066 Fmt 4703 Sfmt 4703 E:\FR\FM\03OCN1.SGM 03OCN1](https://thefederalregister.org/doc/81_FR_68212/page/1.svg)
![Federal Register / Vol. 81, No. 191 / Monday, October 3, 2016 / Notices 68023
22809). After receiving DOT SUPPLEMENTARY INFORMATION: On August DEPARTMENT OF HOMELAND
certification, the laboratory will be 30, 2016, U.S. Customs and Border SECURITY
included in the monthly list of HHS- Protection (CBP) published a notice in
certified laboratories and participate in the Federal Register (81 FR 59644) Federal Emergency Management
the NLCP certification maintenance announcing plans to make the Agency
program. Automated Commercial Environment
(ACE) the sole electronic data [Docket ID: FEMA–2016–0017; OMB No.
Charles LoDico, 1660–0022]
Chemist. interchange (EDI) system authorized by
[FR Doc. 2016–23796 Filed 9–30–16; 8:45 am]
the Commissioner of U.S. Customs and Agency Information Collection
BILLING CODE 4160–20–P
Border Protection (CBP) for processing Activities: Submission for OMB
electronic drawback and duty deferral Review; Comment Request;
entry and entry summary filings, Community Rating System (CRS)
effective on October 1, 2016. The Program—Application Worksheets and
DEPARTMENT OF HOMELAND document also announced that, on Commentary
SECURITY October 1, 2016, the Automated
Commercial System (ACS) would no AGENCY: Federal Emergency
U.S. Customs and Border Protection longer be a CBP-authorized EDI system Management Agency, DHS.
for purposes of processing these ACTION: Notice.
Delay of Effective Date for the
electronic filings. Finally, the notice
Automated Commercial Environment SUMMARY: The Federal Emergency
announced a name change for the ACE Management Agency (FEMA) will
(ACE) Becoming the Sole CBP-
filing code for duty deferral and the submit the information collection
Authorized Electronic Data
Interchange (EDI) System for creation of a new ACE filing code for all abstracted below to the Office of
Processing Electronic Drawback and electronic drawback filings, replacing Management and Budget for review and
Duty Deferral Entry and Entry the six distinct drawback codes clearance in accordance with the
Summary Filings previously filed in ACS. requirements of the Paperwork
CBP has been assessing stakeholder Reduction Act of 1995. The submission
AGENCY: U.S. Customs and Border will describe the nature of the
readiness for the mandatory transition
Protection, Department of Homeland information collection, the categories of
of post-release capabilities in ACE,
Security. respondents, the estimated burden (i.e.,
including the transition of electronic
ACTION: Delay of effective date. the time, effort and resources used by
drawback and duty deferral entry and
entry summary filings from ACS to ACE. respondents to respond) and cost, and
SUMMARY: On August 30, 2016, U.S. the actual data collection instruments
Customs and Border Protection (CBP) CBP has determined that industry
partners need additional time to prepare FEMA will use.
published a notice in the Federal
for the transition to electronic post- DATES: Comments must be submitted on
Register announcing plans to make the
Automated Commercial Environment release capabilities in ACE. or before November 2, 2016.
(ACE) the sole electronic data Accordingly, the effective date for all ADDRESSES: Submit written comments
interchange (EDI) system authorized by that was announced in the August 30, on the proposed information collection
the Commissioner of U.S. Customs and 2016 Federal Register notice, including to the Office of Information and
Border Protection (CBP) for processing the transition to ACE as the sole CBP- Regulatory Affairs, Office of
electronic drawback and duty deferral authorized EDI system for electronic Management and Budget. Comments
entry and entry summary filings. The drawback and duty deferral entry and should be addressed to the Desk Officer
changes announced in that notice were entry summary filings, is delayed until for the Department of Homeland
to have been effective on October 1, further notice. CBP will publish a Security, Federal Emergency
2016. This notice announces that the subsequent notice announcing the Management Agency, and sent via
effective date for the transition to ACE electronic mail to oira.submission@
effective date.
as the sole CBP-authorized EDI system omb.eop.gov.
for electronic drawback and duty Dated: September 28, 2016.
FOR FURTHER INFORMATION CONTACT: Bill
deferral entry and entry summary filings Kevin K. McAleenan, Lesser, Program Specialist, Federal
is delayed until further notice. Deputy Commissioner, U.S. Customs and Insurance and Mitigation
DATES: The effective date is delayed Border Protection. Administration, (202) 646–2807. You
until further notice: CBP will publish a [FR Doc. 2016–23833 Filed 9–30–16; 8:45 am] may contact the Records Management
subsequent notice announcing the BILLING CODE 9111–14–P Division for copies of the proposed
effective date when ACE will be the sole collection of information at email
CBP-authorized EDI system for address: FEMA-Information-Collections-
processing electronic drawback and Management@fema.dhs.gov.
duty deferral entry and entry summary SUPPLEMENTARY INFORMATION: This
filings, and ACS will no longer be a proposed information collection
CBP-authorized EDI system for purposes previously published in the Federal
of processing these filings. Register on July 14, 2016, at 81 FR
sradovich on DSK3GMQ082PROD with NOTICES
FOR FURTHER INFORMATION CONTACT: 45517, with a 60 day public comment
Questions related to this notice may be period. No comments were received.
emailed to ASKACE@cbp.dhs.gov with The purpose of this notice is to notify
the subject line identifier reading ‘‘ACS the public that FEMA will submit the
to ACE Drawback and Duty Deferral information collection abstracted below
Entry and Entry Summary Filings to the Office of Management and Budget
transition’’. for review and clearance.
VerDate Sep<11>2014 17:56 Sep 30, 2016 Jkt 241001 PO 00000 Frm 00068 Fmt 4703 Sfmt 4703 E:\FR\FM\03OCN1.SGM 03OCN1](https://thefederalregister.org/doc/81_FR_68212/page/3.svg)
Document Created: 2018-02-13 14:11:18
Document Modified: 2018-02-13 14:11:18
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice. | |
| Contact | Giselle Hersh, Division of Workplace Programs, SAMHSA/CSAP, 5600 Fishers Lane, Room 16N03A, Rockville, Maryland 20857; 240-276-2600 (voice). | |
| FR Citation | 81 FR 68021 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR